TABLE 4.
Studies regarding mesenchymal stromal cell-conditioned medium for treating wounds in human.
MSC source | Method of tissue extraction | Indication | Study type | Age (years) | Sex (male:female) | Groups of treatments and via of administration | Follow-up (days) | Assessment | Main outcome | |
Prakoeswa et al., 2018 | Human amniotic fluid | Amniocentesis | Chronic plantar ulcer in leprosy | Randomized controlled trial | 52.18 ± 1.33 | 5:6 | Topical application every 3 days - MSC-CM - MSC-CM+vitamin C - MSC-CM+vitamin E (n = 22/group) |
56 | Macroscopic appearance (photography), spectrophotometric | All groups reduced wound size and depth. Healing percentage increased in all groups. Size reduction was 1.7 ± 1.05 vs. 2.01 ± 1.19 vs. 2.84 ± 1.67 cm2, and depth was decreased 0.35 ± 0.14 vs. 0.25 ± 0.11 vs. 0.27 ± 0.15 cm in MSC-CM, MSC-CM+vitamin C, and MSC-CM+vitamin E group, respectively. No adverse events were reported |
CM, conditioned medium; MSC, mesenchymal stromal cells.